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Abstract
Background: Over the last decade tuberculosis (TB) incidence and mortality in Brazil have been steadily declining.
However, this downward trend has not been observed among HIV-infected patients. We describe the epidemiological
and clinical profile of TB patients by HIV status using the Brazilian National Surveillance System.
Methods: All TB diagnoses with HIV status information between January 1, 2007 and December 31, 2011 were
categorized as either HIV or non-HIV at time of TB diagnosis. Co-infected patients (TB-HIV) were compared to TB
patients with no HIV-infection using a hierarchical logistic regression model using Stata 13.0.
Results: The prevalence of TB-HIV co-infection was 19% among adults ≥ 15 years of age. We analyzed data from
243,676 individuals, of whom 46,466 were TB-HIV and 197,210 were only TB cases. The following factors increased risk
of co-infection: male sex (OR: 1.06, 95% CI 1.03-1.10), 20 to 39 years of age (OR = 4.82, 95% CI 4.34-5.36), black (OR = 1.08,
95% CI 1.04-1.13), 4–7 years of education (OR = 1.13, 95% CI 1.19-1.28), diagnosed following default (OR = 2.65, 95% CI
1.13-6.25), presenting with pulmonary and extra-pulmonary forms of TB simultaneously (OR = 2.80, 95% CI 1.56-5.02),
presenting with histopathologic examination suggestive of TB (OR = 2.15, 95% CI 1.13-4.07). Co-infected patients
were less likely to live in rural areas (OR = 0.45, 95% CI 0.42-0.48), have diabetes (OR = 0.45, 95% CI 0.40-0.50) and
be smear positive (OR = 0.55, 95% CI 0.32-0.95), and co-infected patients had higher risk of default (OR = 2.96,
95% CI 2.36-3.71) and death from TB (OR = 5.16, 95% CI 43.04-5.77).
Conclusions: The prevalence of co-infection with HIV among TB patients is 19% in Brazil. By identifying predictors of
co-infection targeted interventions can be developed to prevent both TB and HIV, and to diagnose each disease earlier
and ultimately decrease poor treatment outcomes and death.
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Background
Tuberculosis (TB) remains a serious public health problem,
especially in developing countries like Brazil, which is one of
the 22 high burden countries of the disease worldwide [1].
Over the last decade TB incidence and mortality in Brazil
have been steadily declining. However, this downward trend
has not been observed among HIV-infected patients [2,3].
Since the 1980s, HIV has been one of the main factors
contributing to the resurgence of TB in developed and
developing countries alike [4]. The virus has changed
the natural history of active tuberculosis as well as hav-
ing a marked impact on the epidemiology and clinical
outcomes of TB [5,6]. HIV infected patients have an
annual risk of reactivating latent TB infection between 3
and 15% compared to 0.01 to 0.1% for the general popu-
lation [7].
The implementation of collaborative TB-HIV activities
is still modest in Brazil. These activities include coordin-
ation between the HIV/AIDS and TB programs for
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delivering integrated TB and HIV services including test-
ing TB patients for HIV, providing ART to TB co-
infected patients, providing HIV prevention services for
TB patients, intensifying TB case finding among people
living with HIV, and offering isoniazid preventive ther-
apy. Tuberculosis in HIV-infected patients is often not
identified until death, highlighting a failure of the health
system to detect both diseases earlier [8]. A recent study
of the six Brazilian states with the highest reported levels
of HIV data in the Brazilian national TB reporting
system, reported that 40% of TB patients had no HIV
status provided [9].
Studies conducted in Brazil and other high burden TB
countries have reported several socio-demographic and
clinical features significantly associated with TB-HIV co-
infection [10-12]. However, to the authors’ knowledge,
there has not been such a study done in Brazil using the
Epidemiological Surveillance System. In addition, none
of these studies used models of analysis using the
hierarchical multivariable analysis, which can detect the
factors associated with TB-HIV co-infection relative to
TB only in Brazil.
In this study, we describe the epidemiological and clinical




This is a cross sectional study utilizing the database of the
national TB reporting system (SINAN/TB). SINAN was
developed in the early 90s, with the objective of collecting
and processing data on disease notification throughout
the country. SINAN is the primary information system
from which data are extracted for epidemiological analyses
[13]. This system is available in the website http://dtr2004.
saude.gov.br/sinanweb [14]. Although for this particular
study, data were obtained from the Tuberculosis National
Program at the Ministry of Health in order to avoid repli-
cation and misclassification. These databases support the
improvement of health care systems in Brazil by increas-
ing the capacity of health care workers to make decisions
based on accurate information.
Study population
The population of the study included TB cases aged ≥
15 years reported in Brazil between January 1 2007 and
December 31, 2011.
Variables, data collection
The following socio-demographic covariates were evalu-
ated: age (<20 years, 20–39 years, 40–59 years and ≥
60 years), gender (male, female), skin color (white, black,
mixed and other (Asian and indigenous), school level
(<4 years, 4 to 7 years, ≥ 8 years), area of residence
(urban, rural or peri-urban) and whether the individual
was institutionalized (no or yes). The presence of dia-
betes and alcoholism was included.
The covariates related to TB included the type of TB
diagnosed during the study period, classified as 1) new
TB case (no prior TB diagnoses), relapse (completed a
previous TB treatment) or, 3) return after default (indi-
viduals that defaulted from a previous TB treatment
regimen and returned to continue treatment). We also
included site of TB at presentation (pulmonary, extra
pulmonary, pulmonary + extra pulmonary), localization
of extra-pulmonary TB, tuberculin skin test (positive if
higher than 10 mm), existence of chest X-ray suspicious
for TB, result of initial sputum smear test, result of







Figure 1 Study Flow Diagram; TB-HIV: Tuberculosis and HIV co-infection subjects; TB only: subjects who had only tuberculosis diseases.
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initial culture examination, and result of initial histo-
pathologic examination. Receiving directly observed
therapy (DOT) was also included as a covariate. Final
treatment outcome was classified as cured (completed
treatment and had at least two negative results of
smear examination), default (those that did not attend
to regular appointments for more than 30 days), TB
death, other cause of death (died during TB treatment
of another cause), transferred or developed MDR TB.
Data analysis and statistics
We compared individuals with TB and HIV (TB–HIV)
with those who only had TB (TB only) according to
socio-demographic and clinical characteristics. Pearson
chi-square test was used to compare proportions. Covar-
iates associated (p ≤ 0.05) with the outcome of interest
were included in a hierarchical logistic regression model.
Tuberculosis is a disease with a complex causal chain.
Constructing a hierarchical model may be a better way
to capture the interrelationships between its determi-
nants. In this model, variables are included from distal
to proximal ones, according to different levels of a causal
network arising from a robust theoretical base [15,16].
Associations resulting from the hierarchical regression
model are adjusted for the variables in the same level
and those in previous levels, taking into account both
confounders and mediators [15,16].The present model
was based on the conceptual framework for social deter-
minants of TB formulated by Maciel [17]. In the hier-
archical analysis, the following covariates were included:
step 1 (Gender + age + school level + skin color + Area
of residence); step 2 (variables retained from step 1+
Institutionalization + DOT); step 3 (variables retained
from step 2 Diabetes); step 4 (variables retained from
step 3 + treatment type + TB form + Tuberculin Skin
Test + smear + culture + pathologic examination + X
ray suspicious for TB); and step 5 (variables retained
from step 4 + outcome). In each step, those covariates
associated with the outcome (p ≤ 0.05) were retained in
the model. These analyses were conducted with Stata,
version 13.0.
Due to the high proportion of missing information on
HIV status, we carried out polynomial analysis based on
the following TB treatment outcomes (cure, default,
death from TB, death from other causes and MDR TB)
comparing to HIV status (negative, positive, HIV test
was requested and test not done). Cured TB status was
used as a reference category instead of the present
rendition.
Ethics statement
The databases were obtained under the rules for release
of the Secretariat of Health Surveillance and Health Care
Department of the Ministry of Health, ensuring the
confidentiality and nondisclosure of individual identi-
fiers. The Federal University of Espirito Santo (UFES)
Institutional Review Board approved the study design by
registration number 466/12.
Results
Between 2007 and 2011, 429,567 adult cases of TB were
reported in SINAN, of which 185,891 (43.27%) were
missing data for HIV status. Among 243,676 TB patients
with known HIV status, 46,466 (19%) were TB-HIV
co-infected (Figure 1).
Table 1 Distribution of socio-demographic characteristics
of tuberculosis (TB) cases according to HIV status in
Brazil, 2007-2011
Characteristics (N*) TB-HIV TB only p**
n (%) n (%)
Gender (243,670)
Female 13,899 (29.91) 64,862 (32.89) < 0,001
Male 32,567 (70.09) 132,342 (67.11)
Age (243,676)
<20 years 715 (1.54) 12,042 (6.11) < 0,001
20-39 years 26,610 (57.27) 94,448 (47.89)
40-59 years 17,554 (37.78) 67,495 (34.22)
≥60 years 1,587 (3.42) 23,225 (11.78)
Skin color (225,264)
White 19,919 (47.10) 86,109 (47.06) < 0,001
Black 6,716 (15.88) 23,432 (12.81)
Browns 15,253 (36.06) 70,377 (38.46)
Other 406 (0.96) 3,052 (1.67)
School level (123,482)
<4 years 8,970 (38.06) 42,378 (42.41) < 0,001
4-7 years 7,418 (31.48) 24,672 (24.69)
≥ 8 years 7,179 (30.46) 32,865 (32.89)
Area of residence (165,113)
Urban 32,049 (95.57) 119,150 (90.56) < 0,001
Rural 1,301 (3.88) 11,406 (8.67)
Periurban 186 (0.55) 1,021 (0.78)
Institutionalization*** (202,340)
No 35,878 (92.63) 152,237 (93.05) 0.004
Yes 2,853 (7.37) 11,372 (6.95)
Diabetes (220,039)
No 40,213 (97.35) 166,625 (93.23) < 0,001
Yes 1,095 (2.65) 12,106 (6.77)
Alcoholism (221,868)
No 34,161 (82.60) 149,930 (83.06) 0,027
Yes 7,194 (17.40) 30,583 (16.94)
*Number of valid observations. **Pearson’s chi-squared test. ***prisoners.
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Individuals self-identified as black were more prevalent
in the TB-HIV group (15.88%) compared to the TB only
group (12.81%), (p < 0.001) (Table 1). The proportion of
subjects with < 4 years of education was higher in the
TB only group (42.4%) than TB-HIV group (38.0%),
(p < 0.001). Most individuals lived in urban areas, though
the proportion was slightly higher in the TB-HIV group
(95.57% vs 90.56%) (p < 0.001). Diabetes was less prevalent
in TB–HIV group (2.65%) compared to the TB only group
(6.77%) (p < 0.001). Alcoholism was similar between groups
(17.40% vs 16.94%; p = 0.027).
Table 2 describes the individuals according to character-
istics of TB presentation. New TB cases were reported
more among the TB only group (83.89%) than the TB-
HIV group (73.77%, p < 0.001). A greater proportion of
the TB group (62.41%) had a recorded positive tuberculin
skin test compared to the TB-HIV group (41.17%; p <
0.001). Prevalence of both pulmonary and extrapulmonary
TB in the same individual was more prevalent in the TB –
HIV group (11.90% vs 2.68%, p < 0.001). An X-ray suggest-
ive for TB was found in 86.60% of the TB–HIV group and
94.0% of the TB only group (p < 0.001). On the other
hand, smear and culture positivity were more prevalent
among the TB only group (69.34% vs 52.22%, p < 0.001)
and (60.95% vs 59.24%, p < 0.001), respectively (Table 2).
The histopathologic examination had a higher propor-
tion of AFB positive in the TB-HIV group compared
with the TB only group (46.91% vs 31.93%, p < 0.001).
DOT was greater among the TB only group (53.45% vs
38.32%, p < 0.001) and cure was markedly better as well
(84.95% vs 55.75%; p < 0.001) (Table 2).
The hierarchical multivariate model (Table 3) showed
that individuals aged 20 to 39 years and 40 to 59 years
were more likely to be TB–HIV coinfected compared to
individuals < 20 years of age (OR = 4.82, 95% CI 4.34-5.36
and OR = 3.67, 95% CI 3.30-4.09). Individuals > 60 years of
age did not have higher TB-HIV co-infection compared to
those < 20 years of age. The odds were greater for blacks
to be TB–HIV (OR = 1.08, 95% CI 1.04-1.13) and for those
with school level between 4–7 years (OR = 1.13, 95% CI
1.19-1.28). Living in rural area was protective of being
co-infected (OR = 0.44, 95% CI 0.41-0.48), as well as
having diabetes (OR = 0.45, 95% CI 0.40-0.50).
Patients diagnosed with TB after returning after de-
fault were more likely to be co-infected (OR = 2.65, 95%
CI 1.13-6.25). Both pulmonary and extrapulmonary TB
in the same individual were more likely to be reported
as TB – HIV (OR = 2.80, 95% CI 1.56-5.02). TB–HIV co-
infected patients were less likely to have a positive smear
result (OR = 0.55, 95% CI 0.32-0.95), but more likely to
have a suggestive histopathologic examination (OR = 2.15,
95% CI 1.13-4.07).
Finally, TB–HIV patients were more likely to get unfavor-
able results of tuberculosis treatment including default
(OR = 2.79, 95% CI 2.45-3.18), death from TB (OR = 3.64,
95% CI 2.92-4.53) and death from other causes (OR = 7.93,
95% CI 6.66-9.43).
Table 2 Distribution of presentation and treatment
characteristics of tuberculosis (TB) cases according to HIV
status in Brazil, 2007-2011
Characteristics (N*) TB-HIV TB only P**
n (%) n (%)
Type of Entry (243,676)
New case 34,278 (73.77) 165,449 (83.89) < 0,001
Relapse 4,418 (9.51) 12,235 (6.20)
Return after default 4,681 (10.07) 10,471 (5.31)
Unknown 240 (0.52) 245 (0.12)
Transferred 2,849 (6.13) 8,810 (4.47)
Tuberculin skin test (40,313)
Negative 4,841 (58.83) 12,060 (37.59) < 0,001
Positive 3,388 (41.17) 20,024 (62.41)
TB form (243,670)
Pulmonary 29,738 (64.00) 165,978 (84.16) < 0,001
Extra pulmonary 11,193 (24.09) 25,949 (13.16)
Pulmonary + Extra
pulmonary
5,531 (11.90) 5,281 (2.68)
X-Ray (208,432)
Negative 5,212 (13.40) 10,178 (6.00) < 0,001
Suspicious of TB 33,676 (86.60) 159,366 (94.00)
Smear (199,235)
Negative 15,793 (47.78) 50,945 (30.66) < 0,001
Positive 17,258 (52.22) 115,239 (69.34)
Culture (60,671)
Negative 4,421 (40.76) 19,456 (39.05) < 0,001
Positive 6,425 (59.24) 30,369 (60.95)
Histopathologic
examination (28,618)
AFB*** positive 3,256 (46.91) 6,922 (31.93) < 0,001
Suggestive 3,217 (46.35) 13,411 (61.87)
Not suggestive 468 (6.74) 1,344 (61.87)
DOT**** (226,736)
No 25,644 (61.68) 86,190 (46.55) < 0,001
Yes 15,935 (38.32) 98,967 (53.45)
Outcome (215,884)
Cure 21,404 (55.75) 150,782 (84.95) < 0,001
Default 7,247 (18.88) 17,474 (9.84)
Death from TB 2,700 (7.03) 4,296 (2.42)
Death from other causes 6,835 (17.80 3,895 (2.19)
MDR-TB 206 (0.54) 1.045 (0.59)
*Number of valid observations. **Pearson’s chi-squared test. ***AFB: acid-fast
bacilli.; ****DOT: Directly Observed Therapy.
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Since 43% of subjects with TB were excluded due to
missing information of HIV status, we analyzed the
treatment outcome (cure, default, death from TB, death
from other causes and MDR TB) for HIV status. TB
treatment outcomes were best for those who were
known to be HIV negative and worst for those known to
be HIV positive (data not shown). On the other hand,
TB treatment outcomes for those in whom an HIV test
was requested but the result was not available were
better than those in whom the test was not done. In a
multinomial analysis, considering cure as the reference
group and comparing with HIV status (negative, positive,
test requested but no result recorded and test not done)
showed that death from TB presented an odds ratio of
1.48 with HIV positivity (95% CI 1.43-1.53), whereas the
default was 1.07 (95% CI 1.04-1.10) Table 4.
Discussion
The prevalence of TB – HIV co-infection reported by
SINAN was 19% among TB patients ≥ 15 years of age with
known HIV status. Co-infection was associated with being
male, black, low level of education, living in an urban area
and being between the ages of 20–59 [4,10,18,19]. These
characteristics demonstrate the social characteristics of
HIV-TB co-infection. The same epidemiological profile
has been described in several studies in Brazilian cities
[4,20,21]. These findings have been associated with the
lifestyle of young adults often associated with lack of
awareness of their vulnerability, exposing them to the HIV
virus and tuberculosis [22].
Those socio-demographic characteristics strongly influ-
enced the proportion of TB–HIV co-infection. Since the
beginning of the new century, the AIDS epidemic in Brazil
has reached new population groups and cities where it had
not been previously reported, affecting the less privileged
social segments in the country [3,21,23]. Such populations
have historically been plagued with high TB rates; therefore,
Table 3 Hierarchical* multivariate analysis of the
association of tuberculosis by HIV status
Characteristics OR** 95%CI***
Gender Female Ref.
Level 1 Male 1,06 1.03-1.10
Age <20 years Ref.
20-39 years 4,82 4.34-5.36
40-59 years 3,67 3.30-4.09





Schooling <4 years Ref.
4-7 years 1.23 1.19-1.28
≥ 8 years 0,96 0.92-1.00
Area of residence Urban Ref.
Rural 0,44 0.41-0.48
















Tuberculin skin test Negative Ref.
Positive 0.73 0.50-1.07
TB form Pulmonary Ref.










Not suggestive 0.71 0.37-1.34
X-Ray Negative Ref.
Suspicious of TB 0.62 0.35-1.09
Table 3 Hierarchical* multivariate analysis of the
association of tuberculosis by HIV status (Continued)
Level 5 Outcome Cure Ref.
Default 2.79 2.45-3.18





*The multivariate analyses: step 1 (Gender + age + schooling + race + Area of
residence); step 2 (variables retained from step 1 + Institutionalization + DOT);
step 3 (variables retained from step 2 + Diabetes); step 4 (variables retained
from step 3 + treatment type+ TB form + Tuberculin Skin Test + smear + +
culture + histopathologic examination + X ray suspicious for TB); and step 5
(variables retained from step 4 + outcome). ** Adjusted odds ratio. ***CI:
confidence interval. ****DOT: Directly Observed Therapy. *****AFB:
acid-fast bacilli.
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the introduction of the AIDS epidemic has worsened the
TB problem.
Co-infected patients were less likely to have prevalent
diabetes in our study. It is important to highlight that
TB patients with diabetes have demonstrated worse
outcomes of TB treatment. A study carried out in Brazil
using the Brazilian national surveillance system (SINAN)
demonstrated that TB patients with diabetes were more
likely to die of TB [24].
TB/HIV co-infected patients were less likely to be AFB
positive than TB patients only which can be attributed
to immunodeficiency. This result corroborate with other
published studies which should indicate the need to
develop more sensitive diagnostic techniques to confirm
TB among HIV co-infected such culture. Another tool is
a scoring system used to diagnose smear-negative pul-
monary TB in children and adolescents, in HIV-infected
adults suspected of having smear negative pulmonary TB.
A study conducted in Brazil from a cohort of 2,382 HIV-
infected adults [25], 1276 were investigated and 128 were
diagnosed with pulmonary TB. The scoring system of the
Brazilian Ministry of Health for the diagnosis of pulmon-
ary TB in children and adolescents was adapted by the
authors of the present study for HIV-infected adults and
presented a good capacity for discriminating patients who
did not have pulmonary TB, in the studied population.
The treatment of co-infected TB – HIV patients is dif-
ficult. Patients with TB require long-term treatment with
various medications. For patients with TB-AIDS, adher-
ence with the treatment regimen is difficult due to the
extra burden of drug taking, resulting in higher default
rate as showed in our study [26-28]. Because of this diffi-
culty and poor adherence to tuberculosis treatment, new
strategies for monitoring treatment should be devised, tak-
ing into account the characteristics of the co-infection as
recommended by Brazilian National Tuberculosis Control.
However, in our study the TB – HIV subjects were less
likely to be covered under the DOT, although it was not
statistically significant. This retention in DOT for TB/HIV
co-infected patients was poor in relation to available AIDS
and TB treatment models in Brazil. In addition, in some
Brazilian cities there is no encouragement for patients on
HAART to receive treatment supervision in the commu-
nity such food vouchers and transportation subsidies.
We also found similar results as other studies [3,9,26],
indicating that co-infected patients were more likely to
have unfavorable treatment outcomes (default and death
from TB). The explanation of this unfavorable outcome
in our study is not easy. First, CD4 count is related to
the severity and clinical presentation of tuberculosis in
co-infection, extrapulmonary and disseminated as ob-
served in our study. Second, among co-infected patients,
mortality is commonly related to delayed diagnosis of
TB because some HIV-infected individuals postpone
seeking health care in order to avoid receiving an AIDS
diagnosis [10]. As we can see HIV status plays an import-
ant role in TB treatment outcome. However, for 43% of
patients reported in SINAN during the study period, HIV
status was unknown. This information is similar to what
was found by a study [9] carried out in Brazil, from 2003
to 2008. That study showed that the group with unknown
HIV status showed intermediate outcomes between the
groups above (TB only and TB-HIV), suggesting that this
group includes some with HIV infection.
We analyzed the epidemiological profile of tubercu-
losis patients with unknown HIV status with patients
with known status in our study period, and we observed
that the group with unknown HIV status shared more
similar socio-demographic characteristics with the TB-
HIV group, although some clinical characteristics of dis-
ease were more similar with TB only group as TB form
(pulmonary form was more prevalent, data not shown).
These facts, coupled with what the study [9] cited above
points out, leads us to believe that the group of patients
for which we have no known HIV status is a mix of HIV
positive and negative individuals. We cannot quantify or
identify the direction of the bias our results may have
suffered, but as already mentioned, this is a limitation
that is inherent to operational research using secondary
data such as national disease reporting systems.
Table 4 TB treatment outcomes by HIV status in Brazil, 2007-2011
Outcome HIV status
Negative Positive Test requested but no
result recorded
Test not done
n (%) n (%) n (%) n (%)
Cure 150,782 (84.95) 21,4 (55.75) 24,26 (77.83) 91, 31 (73.99)
Default 17,474 (9.84) 7,24 (18.88) 4,74 (15.23) 19,22 (15.58)
Death from TB 4,296 (2.42) 2,70 (7.03) 978 (3.14) 6,69 (5.42)
Death* 3,895 (2.19) 6,83 (17.80) 1,03 (3.31) 5,75 (4.66)
MDR-TB 1,045 (0.59) 206 (0.54) 153 (0.49) 428 (0.35)
*Death from other causes.
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Our study has some other limitations. Firstly, the propor-
tion of missing data for some variables was quite significant.
Nevertheless, our large sample size still allowed us to main-
tain high statistical power for all analyses, but not account-
ing for potential biases. Secondly, we did not have access to
information about antiretroviral therapy (ART) history or
CD4 count among our group of HIV co-infected patients.
Therefore, we did not know if the patients were diagnosed
with TB prior to, concomitant with, or after the diagnosis
of HIV infection.
Conclusions
Our analysis provides better understanding of the socio-
demographic and clinical differences between HIV and
non-HIV related TB in Brazil, providing evidence for
developing targeted interventions directed towards redu-
cing both infections in high risk groups. We recommend
that the Brazilian National Tuberculosis Control Plan,
which currently recommends all patients diagnosed with
TB be tested for HIV, be strengthened through better
integration and communication between AIDS and TB
programs.
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